Phase II trial of Pemetrexed plus Gemcitabine in patients with advanced non-clear cell renal cell carcinoma

OBJECTIVE: To determine the clinical activity and toxicity of combination pemetrexed and gemcitabine for locally advance and metastatic non-clear cell renal cell carcinoma. METHODS: In this phase II study patients were treated with pemetrexed 500 mg/m(2) IV infusion over 10 minutes(min) on day one f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Richey, Stephen L, Tamboli, Pheroze, Ng, Chaan S, Lin, E, Lim, Zita D, Araujo, John C, Jonasch, Eric, Sharma, Padmanee, Pagliaro, Lance C, Tannir, Nizar M
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3882166/
https://ncbi.nlm.nih.gov/pubmed/22706175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0b013e3182546a91
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados